A New Year Conversation with Dr. Godley

We asked Dr. Mark Godley to reflect on what defined patient care at Godley Clinic in 2025 and what he’s watching as we head into 2026.

Q: Looking back on 2025, what stood out most in your practice?
Dr. Godley: Thread lift and biostimulators dominated 2025. Patients still came in with specific concerns, but the treatments they chose focused on supporting their skin and facial structure over time, not just quick results.

The Invisilift Thread lift, especially for the cheeks and jawline, was one of the most requested procedures. It gave patients lift and support without relying on added volume or surgery.

Q: How did biostimulators fit into that approach?
Dr. Godley: Biostimulators like Radiesse and PRF were a natural pairing. Threads help reposition and support tissue, while biostimulators strengthen the skin and encourage collagen over time. That combination came up again and again in 2025.

This mirrors what’s been happening internationally for a while now. In many European and Asian clinics, the focus is on structure and skin quality first, not filling faces.

Q: Were there any other noticeable patterns in what patients asked for?
Dr. Godley: Lip filler is a good example. Most patients weren’t asking for volume. They wanted hydration and subtle definition. That tells you a lot about how aesthetic preferences have evolved.

Neuromodulators like Botox were still used regularly, particularly for the upper face, but more conservatively. They supported the overall result rather than defining it.

Q: Regenerative medicine is a big part of your work. How does that influence aesthetic care?
Dr. Godley: I’ve always been interested in regenerative medicine and how the body heals and adapts over time. At the end of 2024, we launched our longevity medicine program, and in 2025 it became fully integrated into how we plan aesthetic care.

Instead of separating how someone looks from how they feel, we started pairing aesthetic treatments with conversations about energy, stress, hormones, and recovery. That inside out approach is now built into how care is delivered at our Vancouver and Abbotsford clinics.

Q: You often use a simple analogy to explain peptides. Can you share that?
Dr. Godley: I usually tell patients that peptides are like the text messages on your phone. They’re small signals that tell local tissue what to do.

Peptides provide instructions for healing, replication, and regeneration. They’re naturally found in the body and play a key role in cellular communication.

Many people are already familiar with peptide based therapies without realizing it. Medications like Ozempic, Mounjaro, and Zepbound are peptides. Other peptides, such as BPC 157 and TB500, are known for their anti-inflammatory properties and are being explored in medical contexts.

BPC 157, for example, has been used for inflammatory bowel conditions, and even patients with Celiac disease seem to report positive outcomes when managed appropriately. This is medical treatment, not cosmetic care, which is why physician oversight is essential.

Q: How are peptides used at Godley Clinic?
Dr. Godley: At Godley Clinic, peptides are not a starting point and they’re not for everyone. They’re considered after a detailed review of symptoms, history, and goals, and often alongside other parts of care such as hormone support, longevity medicine, or regenerative aesthetic treatments. Peptides may be used to support healing, reduce inflammation, or improve tissue response so that the body is better supported overall. 

Q: What do you expect will define 2026?
Dr. Godley: 2026 will be about regenerative planning and holistic care.

Patients are increasingly interested in how treatments support tissue health over time. There’s less reliance on filler and more focus on lift, structure, and collagen stimulation. That reflects what we see internationally.

There’s also more overlap between aesthetic care and longevity medicine. Skin, hormones, energy, and aging aren’t separate conversations.

We’re also seeing growing interest from men in cosmetic care. Typically, they’re looking for subtle, structure focused treatments that help them look rested and healthy rather than visibly treated.

Q: Are there any emerging regenerative therapies you’re watching as we move into 2026?
Dr. Godley: One area I’m keeping an eye on is Regenerative Protein Arrays, or RPA. They focus on biological signalling rather than lifting tissue or adding volume, using repair signals the body already recognizes.

There’s growing international interest in this type of acellular regenerative therapy, particularly in Europe and parts of Asia. That said, RPA are not approved by Health Canada and are not used at Godley Clinic. For now, we continue to focus on regenerative treatments that are approved in Canada while watching how this area develops globally.

Q: What’s new at Godley Clinic moving into 2026?
Dr. Godley: In 2026, we’re launching an online questionnaire that allows us to gather more detailed symptom data before appointments. It gives us better insight into patterns around sleep, stress, digestion, and hormonal changes.

Lab work is helpful, but it only represents one point in time. This allows for deeper analysis and more personalized care moving forward.

Q: Any final thoughts as the year comes to an end?
Dr. Godley: Looking back on 2025, what stands out is how much more connected care has become. The work now feels less about individual treatments and more about understanding how the body changes over time and how different forms of care support each other.

That makes this an interesting and rewarding place to be as a physician. Moving into 2026, I’m excited about continuing to refine this inside out approach and building care plans that are thoughtful, personal, and designed to evolve with each patient.

Interested in learning what a long term, inside out approach to aesthetic care could look like for you? Book a consultation with Dr. Godley.